DE60220408D1 - Sequenzielles arzneimittelabgabesystem - Google Patents
Sequenzielles arzneimittelabgabesystemInfo
- Publication number
- DE60220408D1 DE60220408D1 DE60220408T DE60220408T DE60220408D1 DE 60220408 D1 DE60220408 D1 DE 60220408D1 DE 60220408 T DE60220408 T DE 60220408T DE 60220408 T DE60220408 T DE 60220408T DE 60220408 D1 DE60220408 D1 DE 60220408D1
- Authority
- DE
- Germany
- Prior art keywords
- active ingredient
- sequenced
- delivery system
- medicament delivery
- absorption
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
- A61K9/025—Suppositories; Bougies; Bases therefor; Ovules characterised by shape or structure, e.g. hollow layered, coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/901,983 US20030068356A1 (en) | 2001-07-10 | 2001-07-10 | Sequential drug delivery systems |
US901983 | 2001-07-10 | ||
PCT/US2002/021796 WO2003005944A1 (en) | 2001-07-10 | 2002-07-10 | Sequential drug delivery systems |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60220408D1 true DE60220408D1 (de) | 2007-07-12 |
DE60220408T2 DE60220408T2 (de) | 2008-01-31 |
Family
ID=25415151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60220408T Expired - Lifetime DE60220408T2 (de) | 2001-07-10 | 2002-07-10 | Sequenzielles arzneimittelabgabesystem |
Country Status (11)
Country | Link |
---|---|
US (3) | US20030068356A1 (de) |
EP (2) | EP1818029B1 (de) |
JP (1) | JP4617081B2 (de) |
AT (1) | ATE363261T1 (de) |
AU (2) | AU2002320385B2 (de) |
CA (1) | CA2451106C (de) |
DE (1) | DE60220408T2 (de) |
DK (1) | DK1406568T3 (de) |
ES (2) | ES2286263T3 (de) |
HK (1) | HK1106126A1 (de) |
WO (1) | WO2003005944A1 (de) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6974590B2 (en) * | 1998-03-27 | 2005-12-13 | Cima Labs Inc. | Sublingual buccal effervescent |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US20080213363A1 (en) * | 2003-01-23 | 2008-09-04 | Singh Nikhilesh N | Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa |
EP1449525A1 (de) * | 2003-02-20 | 2004-08-25 | Cross Chem Llc | Kaugummi in der Form von Mehrschichttabletten |
UA81335C2 (uk) * | 2003-07-11 | 2007-12-25 | Ф.Хоффманн-Ля Рош Аг | Оральна дозована форма саквінавіру мезилату |
BRPI0412523A (pt) * | 2003-07-11 | 2006-09-19 | Hoffmann La Roche | forma de dosagem oral de mesilato de saquinavir |
DE602004031462D1 (de) | 2003-12-31 | 2011-03-31 | Cima Labs Inc | Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung |
US7858121B2 (en) | 2003-12-31 | 2010-12-28 | Cima Labs, Inc. | Effervescent oral fentanyl dosage form and methods of administering fentanyl |
MXPA06007453A (es) * | 2003-12-31 | 2007-01-31 | Cima Labs Inc | Forma de dosificacion de opiaceo oral efervescente. |
KR20140104986A (ko) * | 2004-02-17 | 2014-08-29 | 트랜스셉트 파마슈티칼스, 인코포레이티드 | 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법 |
US7615028B2 (en) | 2004-12-03 | 2009-11-10 | Chf Solutions Inc. | Extracorporeal blood treatment and system having reversible blood pumps |
GB0509317D0 (en) * | 2005-05-06 | 2005-06-15 | Clarke Anthony | Pharmaceutical formulation of apomorphine |
US20070287740A1 (en) * | 2005-05-25 | 2007-12-13 | Transcept Pharmaceuticals, Inc. | Compositions and methods of treating middle-of-the night insomnia |
US20070123562A1 (en) * | 2005-05-25 | 2007-05-31 | Transoral Pharmaceuticals, Inc. | Compositions and methods for treating middle-of-the-night insomnia |
US20070225322A1 (en) * | 2005-05-25 | 2007-09-27 | Transoral Pharmaceuticals, Inc. | Compositions and methods for treating middle-of-the night insomnia |
US8753308B2 (en) | 2006-01-06 | 2014-06-17 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US9066847B2 (en) | 2007-01-05 | 2015-06-30 | Aceirx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
US8357114B2 (en) | 2006-01-06 | 2013-01-22 | Acelrx Pharmaceuticals, Inc. | Drug dispensing device with flexible push rod |
US8252329B2 (en) | 2007-01-05 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US8252328B2 (en) | 2006-01-06 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US8865743B2 (en) | 2006-01-06 | 2014-10-21 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US8202535B2 (en) | 2006-01-06 | 2012-06-19 | Acelrx Pharmaceuticals, Inc. | Small-volume oral transmucosal dosage forms |
US8535714B2 (en) | 2006-01-06 | 2013-09-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US9289583B2 (en) | 2006-01-06 | 2016-03-22 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
EP1980240A1 (de) * | 2007-04-11 | 2008-10-15 | Cephalon France | Lyophilisierte pharmazeutische Zusammensetzungen und Verfahren zu ihrer Herstellung und Verwendung |
WO2009081411A2 (en) * | 2007-12-26 | 2009-07-02 | Rainbow Medical | Nitric oxide generation to treat female sexual dysfunction |
US20090198271A1 (en) * | 2008-01-31 | 2009-08-06 | Rainbow Medical Ltd. | Electrode based filter |
EA201100313A1 (ru) * | 2008-09-09 | 2011-10-31 | Астразенека Аб | Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом |
US8945592B2 (en) | 2008-11-21 | 2015-02-03 | Acelrx Pharmaceuticals, Inc. | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
MX2011010621A (es) * | 2009-04-09 | 2012-01-30 | Alkermes Pharma Ireland Ltd | Composiciones de clozapina de liberacion controlada. |
EA025054B1 (ru) | 2009-06-12 | 2016-11-30 | Сайнэпсус Терапьютикс, Инк. | Единичная дозированная форма для сублингвального введения, включающая частицы апоморфина, для лечения болезни паркинсона или половой дисфункции |
AU2010263304A1 (en) | 2009-06-25 | 2012-02-02 | Astrazeneca Ab | Method for treating a patient at risk for developing an NSAID-associated ulcer |
WO2011025673A1 (en) * | 2009-08-26 | 2011-03-03 | Aptapharma, Inc. | Multilayer minitablets |
US20110202108A1 (en) * | 2010-02-18 | 2011-08-18 | Rainbow Medical Ltd. | Electrical menorrhagia treatment |
US8529914B2 (en) * | 2010-06-28 | 2013-09-10 | Richard C. Fuisz | Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive |
PL2651357T3 (pl) | 2010-12-16 | 2020-08-24 | Sunovion Pharmaceuticals Inc. | Filmy podjęzykowe |
CN105963685B (zh) | 2010-12-16 | 2021-01-15 | 诺和诺德股份有限公司 | 包含glp-1激动剂和n-(8-(2-羟基苯甲酰)氨基)辛酸盐的固体组合物 |
CA2832811A1 (en) | 2011-04-12 | 2012-10-18 | Novo Nordisk A/S | Double-acylated glp-1 derivatives |
EP3939569A1 (de) | 2011-09-19 | 2022-01-19 | Orexo AB | Neue missbrauchssichere pharmazeutische zusammensetzung zur behandlung von opiatsucht |
WO2013101897A2 (en) | 2011-12-28 | 2013-07-04 | Pozen Inc. | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
DK2827845T3 (en) | 2012-03-22 | 2019-04-01 | Novo Nordisk As | COMPOSITIONS INCLUDING A PROCEDURE AND PREPARING THEREOF |
WO2013139694A1 (en) | 2012-03-22 | 2013-09-26 | Novo Nordisk A/S | Compositions of glp-1 peptides and preparation thereof |
EP2827845B1 (de) | 2012-03-22 | 2018-12-26 | Novo Nordisk A/S | Zusammensetzungen mit zuführungsmittel und ihre herstellung |
US10588857B2 (en) | 2012-03-29 | 2020-03-17 | Therabiome, Llc | Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix |
LT2849730T (lt) | 2012-05-02 | 2016-12-27 | Orexo Ab | Nauja alfentanilo kompozicija, skirta ūmaus skausmo gydymui |
JP6517690B2 (ja) | 2012-06-20 | 2019-05-22 | ノヴォ ノルディスク アー/エス | ペプチド及び送達剤を含む錠剤製剤 |
CN110075130A (zh) | 2013-03-14 | 2019-08-02 | 塞拉拜姆有限责任公司 | 益生生物和/或治疗剂的靶向胃肠道递送 |
WO2016106329A1 (en) | 2014-12-23 | 2016-06-30 | Acelrx Pharmaceuticals, Inc. | Systems, devices and methods for dispensing oral transmucosal dosage forms |
CA3127926A1 (en) | 2015-04-21 | 2016-10-27 | Sunovion Pharmaceuticals Inc. | Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa |
CA3087928A1 (en) | 2018-02-02 | 2019-08-08 | Novo Nordisk A/S | Solid compositions comprising a glp-1 agonist, a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid and a lubricant |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3131123A (en) * | 1959-03-13 | 1964-04-28 | Lab Francais De Therapeutique | Enteric tablets and manufacture thereof |
US4443428A (en) * | 1982-06-21 | 1984-04-17 | Euroceltique, S.A. | Extended action controlled release compositions |
US4452808A (en) * | 1982-12-07 | 1984-06-05 | Smithkline Beckman Corporation | 4-Aminoalkyl-2(3H)-indolones |
US4756710A (en) | 1985-04-05 | 1988-07-12 | Merck & Co., Inc. | pH-Mediated drug delivery system |
US4764375A (en) | 1985-09-11 | 1988-08-16 | Kv Pharmaceutical Company | Sachet drug delivery system |
GB8820327D0 (en) * | 1988-08-26 | 1988-09-28 | May & Baker Ltd | New compositions of matter |
DE3838431A1 (de) * | 1988-11-12 | 1990-05-17 | Bayer Ag | Ibuprofen-brausezubereitungen |
US5178878A (en) * | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
EP0737473A1 (de) * | 1989-10-02 | 1996-10-16 | Cima Labs, Inc. | Brausedosisform |
IT1246382B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
US5102666A (en) * | 1990-09-11 | 1992-04-07 | Oramed, Inc. | Calcium polycarbophil controlled release composition and method |
TW212139B (de) * | 1991-04-15 | 1993-09-01 | Yamanouchi Pharma Co Ltd | |
US5503846A (en) * | 1993-03-17 | 1996-04-02 | Cima Labs, Inc. | Base coated acid particles and effervescent formulation incorporating same |
IT1270831B (it) | 1993-09-17 | 1997-05-13 | Romano Deghenghi | Composizioni farmaceutiche orali effervescenti contenenti estrone |
KR100195873B1 (ko) * | 1994-03-07 | 1999-06-15 | 챨스 디 에버트 | 약물을 포함하는 접착성 복합 경피수송 장치 |
WO1995025504A1 (en) * | 1994-03-18 | 1995-09-28 | Pharmavene, Inc. | Emulsified drug delivery systems |
JP3170139B2 (ja) | 1994-04-08 | 2001-05-28 | エスエス製薬株式会社 | 発泡性錠剤 |
CA2187023A1 (en) * | 1994-04-13 | 1995-10-26 | Steven Andrew Giannos | Temporally controlled drug delivery systems |
NZ288185A (en) | 1994-06-15 | 1998-02-26 | Dumex Alpharma As | Particulate pharmaceutical formulation containing coated cores comprising at least 80% of an inert carrier having a friability of <20%; the inert carrier can be calcium carbonate |
GB9417524D0 (en) * | 1994-08-31 | 1994-10-19 | Cortecs Ltd | Pharmaceutical compositions |
CA2160423A1 (en) * | 1994-11-02 | 1996-05-03 | Hemant N. Joshi | Salts of nefazodone having improved dissolution rates |
FR2732217B1 (fr) * | 1995-03-29 | 1997-06-06 | Hesnard Xavier | Forme d'administration solide a usage oral |
GB9510830D0 (en) * | 1995-05-27 | 1995-07-19 | Zeneca Ltd | Proteins |
US5607697A (en) * | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
GB9517062D0 (en) * | 1995-08-18 | 1995-10-25 | Scherer Ltd R P | Pharmaceutical compositions |
CN1207675A (zh) | 1995-11-06 | 1999-02-10 | 萨默塞特药品有限公司 | 丙炔苯丙胺的经颊和舌下给药法 |
EP1062952B1 (de) | 1998-03-11 | 2003-08-06 | Grelan Pharmaceutical Co., Ltd. | Darmlösliche sprudelnde zusammensetzungen |
US6200604B1 (en) * | 1998-03-27 | 2001-03-13 | Cima Labs Inc. | Sublingual buccal effervescent |
US6974590B2 (en) * | 1998-03-27 | 2005-12-13 | Cima Labs Inc. | Sublingual buccal effervescent |
US20030118645A1 (en) * | 1998-04-29 | 2003-06-26 | Pather S. Indiran | Pharmaceutical compositions for rectal and vaginal administration |
US6350470B1 (en) * | 1998-04-29 | 2002-02-26 | Cima Labs Inc. | Effervescent drug delivery system for oral administration |
US20030091629A1 (en) * | 1998-03-27 | 2003-05-15 | Cima Labs Inc. | Sublingual buccal effervescent |
DE19814257A1 (de) | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Brauseformulierungen |
US6312728B1 (en) * | 1998-07-07 | 2001-11-06 | Cascade Development, Inc. | Sustained release pharmaceutical preparation |
WO2000009093A1 (en) | 1998-08-13 | 2000-02-24 | Cima Labs Inc. | Microemulsions as solid dosage forms for oral administration |
AU2367900A (en) * | 1998-12-18 | 2000-07-03 | Bayer Corporation | Chewable drug delivery system |
US6210699B1 (en) | 1999-04-01 | 2001-04-03 | Watson Pharmaceuticals, Inc. | Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity |
US6326384B1 (en) * | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
US6264981B1 (en) * | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
US7858121B2 (en) * | 2003-12-31 | 2010-12-28 | Cima Labs, Inc. | Effervescent oral fentanyl dosage form and methods of administering fentanyl |
MXPA06007453A (es) * | 2003-12-31 | 2007-01-31 | Cima Labs Inc | Forma de dosificacion de opiaceo oral efervescente. |
DE602004031462D1 (de) * | 2003-12-31 | 2011-03-31 | Cima Labs Inc | Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung |
US20070036853A1 (en) * | 2003-12-31 | 2007-02-15 | Cima Labs Inc. | Generally linear effervescent oral fentanyl dosage form and methods of administering |
-
2001
- 2001-07-10 US US09/901,983 patent/US20030068356A1/en not_active Abandoned
-
2002
- 2002-07-10 ES ES02749899T patent/ES2286263T3/es not_active Expired - Lifetime
- 2002-07-10 DE DE60220408T patent/DE60220408T2/de not_active Expired - Lifetime
- 2002-07-10 ES ES07006505.7T patent/ES2604780T3/es not_active Expired - Lifetime
- 2002-07-10 EP EP07006505.7A patent/EP1818029B1/de not_active Expired - Lifetime
- 2002-07-10 AT AT02749899T patent/ATE363261T1/de active
- 2002-07-10 AU AU2002320385A patent/AU2002320385B2/en not_active Ceased
- 2002-07-10 EP EP02749899A patent/EP1406568B1/de not_active Expired - Lifetime
- 2002-07-10 WO PCT/US2002/021796 patent/WO2003005944A1/en active IP Right Grant
- 2002-07-10 JP JP2003511754A patent/JP4617081B2/ja not_active Expired - Fee Related
- 2002-07-10 DK DK02749899T patent/DK1406568T3/da active
- 2002-07-10 CA CA002451106A patent/CA2451106C/en not_active Expired - Fee Related
-
2003
- 2003-07-18 US US10/623,069 patent/US20030232080A1/en not_active Abandoned
-
2004
- 2004-09-08 US US10/936,185 patent/US7670617B2/en not_active Expired - Fee Related
-
2007
- 2007-10-26 HK HK07111607.5A patent/HK1106126A1/zh not_active IP Right Cessation
-
2008
- 2008-08-01 AU AU2008203464A patent/AU2008203464B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
DK1406568T3 (da) | 2007-10-01 |
AU2002320385B2 (en) | 2008-05-01 |
JP4617081B2 (ja) | 2011-01-19 |
EP1406568A4 (de) | 2004-12-15 |
EP1818029A2 (de) | 2007-08-15 |
EP1406568B1 (de) | 2007-05-30 |
EP1406568A1 (de) | 2004-04-14 |
AU2008203464A1 (en) | 2008-08-21 |
EP1818029B1 (de) | 2016-09-07 |
US20050031677A1 (en) | 2005-02-10 |
AU2008203464B2 (en) | 2010-07-01 |
CA2451106C (en) | 2009-12-22 |
US20030232080A1 (en) | 2003-12-18 |
CA2451106A1 (en) | 2003-01-23 |
JP2004534839A (ja) | 2004-11-18 |
ES2604780T3 (es) | 2017-03-09 |
US7670617B2 (en) | 2010-03-02 |
EP1818029A3 (de) | 2008-06-11 |
ES2286263T3 (es) | 2007-12-01 |
WO2003005944A1 (en) | 2003-01-23 |
ATE363261T1 (de) | 2007-06-15 |
US20030068356A1 (en) | 2003-04-10 |
DE60220408T2 (de) | 2008-01-31 |
HK1106126A1 (zh) | 2008-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60220408D1 (de) | Sequenzielles arzneimittelabgabesystem | |
DE60027921D1 (de) | Vorrichtung zur gleichzeitigen verabreichung von gasen und medikamenten | |
ATE450252T1 (de) | Arzneimittel-mikroteilchen | |
IS6557A (is) | Blandaðar sjúkdómsmeðferðir úr blóðþrýstingslækkandi efnum og efnum sem hamla æðamyndun | |
ATE468845T2 (de) | Bukkale transmukosale arzneidarreichung unter verwendung einer festen lösung | |
NO20062504L (no) | Sammensetninger og doseringsformer for forbedret absorpsjon | |
HUP9902076A2 (hu) | Szexuális rendellenességek kezelésére alkalmas intranazális készítmény | |
ATE387430T1 (de) | Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe | |
ATE309798T1 (de) | Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate | |
CY1109861T1 (el) | Διαδερμικο θεραπευτικο συστημα για την ασθενεια του παρκινσον που προκαλει υψηλα επιπεδα πλασματος της ροτιγοτινης | |
DE69919713D1 (de) | Pharmazeutische zubereitung mit verzögerter wirkstofffreisetzung von phenytoin natrium | |
SE0102276D0 (sv) | Device and method for the administration of a medicament | |
WO2002013801A3 (en) | Method of treating the syndrome of coronary heart disease risk factors in humans | |
HUP0002490A2 (hu) | Csersav-polimer kompozíciók gyógyászati anyagok szabályozott leadására, különösen a szájüregben | |
EA200600817A1 (ru) | Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты) | |
NO20023464D0 (no) | Sammensetning for intestinal avlevering | |
BR9812553A (pt) | Formulação medicamentosa com liberação de substância ativa controlada | |
BRPI0406858A (pt) | Liberação controlada de agentes altamente solúveis | |
DK1343472T3 (da) | Thixotropisk næsespray | |
ATE374600T1 (de) | Pharmazeutische formulierung enthaltend olanzapin | |
ATE395064T1 (de) | Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen | |
ATE340576T1 (de) | Wirkstoff-kombination zur medikamentösen therapie der nikotinabhängigkeit | |
BR0317292A (pt) | Derivados de amida de ácido antranìlico e seu uso farmacêutico | |
WO2002072016A3 (en) | Method of preventing adhesions with ifn-¿y? | |
ATE462411T1 (de) | Darreichungssysteme von wirkstoffen und methoden zum schutz und zur verabreichung von wirkstoffen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |